Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Diseases and Conditions
  3. Hepatitis
  4. Hepatitis B
  5. Perinatal Hepatitis B
Topic Menu

Perinatal Hepatitis B

  • Perinatal Hepatitis B Home
  • About Perinatal Hepatitis B
  • For Health Professionals
  • Minnesota Program & Statistics

Related Topics

  • Hepatitis Home
  • Immunization
  • STDs
  • Foodborne Illness
  • Infectious Diseases A-Z
  • Reportable Infectious Diseases

Perinatal Hepatitis B

  • Perinatal Hepatitis B Home
  • About Perinatal Hepatitis B
  • For Health Professionals
  • Minnesota Program & Statistics

Related Topics

  • Hepatitis Home
  • Immunization
  • STDs
  • Foodborne Illness
  • Infectious Diseases A-Z
  • Reportable Infectious Diseases
Contact Info
Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Contact Info

Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Minnesota Perinatal Hepatitis B Program and Statistics

We implemented a perinatal hepatitis B prevention program in 1990. Our goal is to identify and treat infants born to hepatitis B-positive people in an effort to prevent perinatally acquired infection. The benefits of this cost-effective strategy are preventing potential long-term health consequences for the child and eliminating a potential source of infection to others in the future.

The program provides case management to infants born to hepatitis B positive people. Of these infants, over 99% received treatment (consisting of vaccine and hepatitis B immune globulin) at birth.

Hepatitis B is transmitted very efficiently from an infected birthing parent to the infant at birth. If infected, up to 90% of babies will develop chronic hepatitis B infection which can lead to liver damage, liver failure, liver cancer and even death. Treatment initiated within 12 hours after birth is up to 94% effective at preventing this serious infection. Prevention efforts depend upon maintaining high treatment rates.

YearNumber of infants born to hepatitis B-positive people in MNNumber of infants identified as hepatitis B-positive during reporting year
20144430
20154093
20164281
20174130
20183750
20193880
20203450
20213270
20223182
20233330

Disease Control Newsletter (DCN)

Disease Control Newsletter (DCN) is MDH's surveillance information on certain communicable diseases in Minnesota.

  • Disease Control Newsletter (DCN)
    The DCN archives available on the web include 1997-2022.
Tags
  • hepatitis
Last Updated: 06/11/2025

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube